Baudax Bio, Inc.
NANOPARTICULATE MELOXICAM FORMULATIONS
Last updated:
Abstract:
The present invention is directed to nanoparticulate compositions comprising meloxicam particles having an effective average particle size of less than about 2000 nm.
Status:
Application
Type:
Utility
Filling date:
5 Jun 2020
Issue date:
22 Apr 2021